The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ

Epidemiological evidences suggested that 5-aminosalicylic acid (5-ASA) therapy may prevent the development of colorectal cancer in inflammatory bowel disease patients. Our aim is to investigate whether peroxisome proliferator-activated receptor-γ (PPARγ) mediates the antineoplastic effects of 5-ASA....

Descripción completa

Detalles Bibliográficos
Autores principales: Rousseaux, Christel, El-Jamal, Noura, Fumery, Mathurin, Dubuquoy, Caroline, Romano, Olivier, Chatelain, Denis, Langlois, Audrey, Bertin, Benjamin, Buob, David, Colombel, Jean Frederic, Cortot, Antoine, Desreumaux, Pierre, Dubuquoy, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810841/
https://www.ncbi.nlm.nih.gov/pubmed/23843037
http://dx.doi.org/10.1093/carcin/bgt245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810841/
https://www.ncbi.nlm.nih.gov/pubmed/23843037
http://dx.doi.org/10.1093/carcin/bgt245

Ejemplares similares